Jonas Ristau
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
A fully automated machine-learning-based workflow for radiation treatment planning in prostate cancer.
Journal: Clinical and translational radiation oncology
Published: November 23, 2024
Dosimetric benefit of online treatment plan adaptation in stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer.
Journal: Frontiers in oncology
Published: October 06, 2023
Stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer - Acute toxicity and patient-reported outcomes in the prospective, multicenter SMILE phase II trial.
Journal: Clinical and translational radiation oncology
Published: September 22, 2023
Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk.
Journal: Clinical and translational radiation oncology
Published: November 29, 2022
MR-linac based radiation therapy in gastrointestinal cancers: a narrative review.
Journal: Journal of gastrointestinal oncology
Published: September 29, 2022
A body mass index-based method for "MR-only" abdominal MR-guided adaptive radiotherapy.
Journal: Zeitschrift fur medizinische Physik
Published: August 09, 2022
Detecting and Locating the Site of Local Relapse Using 18F-PSMA-1007 Imaging After Primary Treatment of 135 Prostate Cancer Patients-Potential Impact on PSMA-Guided Radiation Therapy.
Journal: Molecular imaging and biology
Published: May 11, 2022
Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial.
Journal: Radiation oncology (London, England)
Published: February 17, 2022
Magnetic resonance guided adaptive stereotactic body radiotherapy for lung tumors in ultracentral location: the MAGELLAN trial (ARO 2021-3).
Journal: Radiation oncology (London, England)
Published: January 31, 2022
MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
Journal: Radiation oncology (London, England)
Published: January 28, 2022
SMART ablation of lymphatic oligometastases in the pelvis and abdomen: Clinical and dosimetry outcomes.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: November 26, 2021
Last Updated: 09/26/2026